Startup Aims to Revive Failed Drug

A London-based startup is making a risky bet that a surprising genetic variation will enable it to find success in one of the pharmaceutical industry’s biggest flops.

from WSJ.com: US Business http://ift.tt/1MEHSaC
via IFTTT